• 1
    Afeltra, A., Galeazzi, M., Ferri, G. M., Amoroso, A., De Pita, O., Porzio, F. and Bonomo, L., Expression of CD69 antigen on synovial fluid T cells in patients with rheumatoid arthritis and other chronic synovitis. Ann. Rheum. Dis. 1993. 52: 457460.
  • 2
    Klareskog, L., Forsum, U., Malmnas Tjernlund, U. K., Kabelitz, D. and Wigren, A., Appearance of anti-HLA-DR-reactive cells in normal and rheumatoid synovial tissue. Scand. J. Immunol. 1981. 14: 183192.
  • 3
    Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M., Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995. 155: 11511164.
  • 4
    Shevach, E. M., Regulatory T cells in autoimmunity. Annu. Rev. Immunol. 2000. 18: 423449.
  • 5
    Stephens, L. A., Mottet, C., Mason, D. and Powrie, F., Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 2001. 31: 12471254.
  • 6
    Taams, L. S., Smith, J., Rustin, M. H., Salmon, M., Poulter, L. W. and Akbar, A. N., Human anergic/suppressive CD4+CD25+ T cells: a highly differentiated and apoptosis-prone population. Eur. J. Immunol. 2001. 31: 11221131.
  • 7
    Sakaguchi, S., Fukuma, K., Kuribayashi, K. and Masuda, T., Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med. 1985. 161: 7287.
  • 8
    Sakaguchi, S., Takahashi, T. and Nishizuka, Y., Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J. Exp. Med. 1982. 156: 15771586.
  • 9
    Suri-Payer, E., Amar, A. Z., Thornton, A. M. and Shevach, E. M., CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol. 1998. 160: 12121218.
  • 10
    Baecher-Allan, C., Brown, J. A., Freeman, G. J. and Hafler, D. A., CD4+CD25high regulatory cells in human peripheral blood. J. Immunol. 2001. 167: 12451253.
  • 11
    Kuniyasu, Y., Takahashi, T., Itoh, M., Shimizu, J., Toda, G. and Sakaguchi, S., Naturally anergic and suppressive CD25+CD4+ T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int. Immunol. 2000. 12: 11451155.
  • 12
    Shevach, E. M., Certified professionals: CD4+CD25+ suppressor T cells. J. Exp. Med. 2001. 193: F4146.
  • 13
    Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J. and Enk, A. H., Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolatedfrom peripheral blood. J. Exp. Med. 2001. 193: 12851294.
  • 14
    Levings, M. K., Sangregorio, R. and Roncarolo, M. G., Human CD25+CD4+ T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med. 2001. 193: 12951302.
  • 15
    Dieckmann, D., Plottner, H., Berchtold, S., Berger, T. and Schuler, G., Ex vivo isolation and characterization of CD4+CD25+ T cells with regulatory properties from human blood. J. Exp. Med. 2001. 193: 13031310.
  • 16
    Shimizu, J., Yamazaki, S. and Sakaguchi, S., Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J. Immunol. 1999. 163: 52115218.
  • 17
    Thornton, A. M. and Shevach, E. M., CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 1998. 188: 287296.
  • 18
    Smeets, T., Dolhain, R., Miltenburg, A., de Kuiper, R., Breedveld, F. and Tak, P., Poor expression of T cell-derived cytokines and activation and proliferation markers in early rheumatoid synovial tissue. Clin. Immunol. Immunopathol. 1998. 88: 8490.
  • 19
    Green, E., Choi, Y. and Flavell, R., Pancreatic lymph node-derived CD4+CD25+ Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. Immunity 2002. 16: 183191.
  • 20
    Iellem, A., Mariani, M., Lang, R., Recalde, H., Panina-Bordignon, P., Sinigaglia, F. and D'Ambrosio, D., Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+CD25+ regulatory T cells. J. Exp. Med. 2001. 194: 847854.
  • 21
    Suzuki, N., Nakajima, A., Yoshino, S., Matsushima, K., Yagita, H. and Okumura, K., Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. Int. Immunol. 1999. 11: 553559.
  • 22
    Thompson, S. D., Luyrink, L. K., Graham, T. B., Tsoras, M., Ryan, M., Passo, M. H. and Glass, D. N., Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratios. J. Immunol. 2001. 166: 68996906.
  • 23
    Santiago-Schwarz, F., Anand, P., Liu, S. and Carsons, S. E., Dendritic cells (DCs) in rheumatoid arthritis (RA): progenitor cells and soluble factors contained in RA synovial fluid yield a subset of myeloid DCs that preferentially activate TH1 inflammatory-type responses. J. Immunol. 2001. 167: 17581768.
  • 24
    Pettit, A. R., Ahern, M. J., Zehntner, S., Smith, M. D. and Thomas, R., Comparison of differentiated dendritic cell infiltration of autoimmune and osteoarthritis synovial tissue. Arthritis Rheum. 2001. 44: 105110.
  • 25
    Vink, A., Uyttenhove, C., Wauters, P. and Van Snick, J., Accessory factors involved in murine T cell activation. Distinct roles of interleukin 6, interleukin 1 and tumor necrosis factor. Eur. J. Immunol. 1990. 20: 16.
  • 26
    Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E. and Roncarolo, M. G., A CD4+ T cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature 1997. 389: 737742.
  • 27
    Barrat, F., Cua, D., Boonstra, A., Richards, D., Crain, C., Savelkoul, H., de Waal-Malefyt, R., Coffman, R., Hawrylowicz, C. and O'Garra, A., In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 2002. 195: 603616.
  • 28
    Berg, L., Ronnelid, J., Klareskog, L. and Bucht, A., Down-regulation of the T cell receptor CD3 zeta chain in rheumatoid arthritis (RA) and its influence on T cell responsiveness. Clin. Exp. Immunol. 2000. 120: 174182.
  • 29
    Emery, P., Panayi, G. S. and Nouri, A. M., Interleukin-2 reverses deficient cell-mediated immune responses in rheumatoid arthritis. Clin. Exp. Immunol. 1984. 57: 123129.
  • 30
    Arnett, F. C., Edworthy, S. M., Bloch, D. A., McShane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S. and et al., The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988. 31: 315324.